18F-F-PEB

N/A

Report date: 2025/11/24 17:27:51
NME

Base Information

Drug Name18F-F-PEB
Drug Alias Name[18F]FPEB18F-F-PEB
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsAutistic DisorderMarijuana AbuseFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co IncUniversity Hospital, Tours
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale UniversityUniversity Hospital, Tours
Active IndicationsN/A
Inactive IndicationsAutistic DisorderMarijuana AbuseFragile X Syndrome

Other Information

ATC CodeN/A
Related LinksN/A